Telix Pharmaceuticals Ltd - Ordinary Shares (TLX)

CUSIP: 87961M105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Ordinary Shares
Shares outstanding
334,705,968
Total 13F shares
3,730
Share change
+3,730
Total reported value
$57,442
Price per share
$15.40
Number of holders
1
Value change
+$57,442
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 87961M105?
CUSIP 87961M105 identifies TLX - Telix Pharmaceuticals Ltd - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Telix Pharmaceuticals Ltd - Ordinary Shares (TLX) as of Q4 2024

As of 31 Dec 2024, Telix Pharmaceuticals Ltd - Ordinary Shares (TLX) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 3,730 shares. The largest 1 holders included UBS Group AG. This page lists 1 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.